1BCV - Header Asymmetric Unit

HEADER SYNTHETIC PEPTIDE 03-MAY-98 1BCV

TITLE SYNTHETIC PEPTIDE CORRESPONDING TO THE MAJOR IMMUNOGEN SITE TITLE 2 OF FMD VIRUS, NMR, 10 STRUCTURES

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDE CORRESPONDING TO THE MAJOR IMMUNOGEN COMPND 3 SITE OF FMD VIRUS; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES

SOURCE MOL_ID: 1

KEYWDS SYNTHETIC PEPTIDE, ANTIGENE

EXPDTA SOLUTION NMR

NUMMDL 10

AUTHOR M.C.PETIT,N.BENKIRANE,G.GUICHARD,A.PHAN CHAN DU,M.T.CUNG, AUTHOR 2 J.P.BRIAND,S.MULLER

REVDAT 3 24-FEB-09 1BCV 1 VERSN REVDAT 2 13-JAN-99 1BCV 1 SOURCE COMPND REMARK TITLE REVDAT 1 25-NOV-98 1BCV 0

JRNL AUTH M.C.PETIT,N.BENKIRANE,G.GUICHARD,A.P.DU,M.MARRAUD, JRNL AUTH 2 M.T.CUNG,J.P.BRIAND,S.MULLER JRNL TITL SOLUTION STRUCTURE OF A RETRO-INVERSO PEPTIDE JRNL TITL 2 ANALOGUE MIMICKING THE FOOT-AND-MOUTH DISEASE JRNL TITL 3 VIRUS MAJOR ANTIGENIC SITE. STRUCTURAL BASIS FOR JRNL TITL 4 ITS ANTIGENIC CROSS-REACTIVITY WITH THE PARENT JRNL TITL 5 PEPTIDE. JRNL REF J.BIOL.CHEM. V. 274 3686 1999 JRNL REFN ISSN 0021-9258 JRNL PMID 9920919 JRNL DOI 10.1074/JBC.274.6.3686

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.4 REMARK 3 AUTHORS : GUNTERT,WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESTRAINED ENERGY REFINEMENT.

REMARK 4 REMARK 4 1BCV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 285 REMARK 210 PH : 5.7 REMARK 210 IONIC STRENGTH : 0.1M PHOSPHATE REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : COSY, TOCSY, ROESY, NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ REMARK 210 SPECTROMETER MODEL : DRX400 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : DYANA-1.4 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 142 59.47 -99.15 REMARK 500 1 VAL A 144 116.49 175.11 REMARK 500 1 ALA A 156 -46.25 -139.59 REMARK 500 2 SER A 142 173.49 -51.61 REMARK 500 2 VAL A 144 116.47 175.10 REMARK 500 2 ALA A 156 -46.25 -139.55 REMARK 500 3 VAL A 144 116.43 175.03 REMARK 500 3 ASP A 147 159.86 -47.36 REMARK 500 3 ARG A 154 71.12 -111.01 REMARK 500 3 ALA A 156 -46.25 -139.58 REMARK 500 4 VAL A 144 116.49 175.07 REMARK 500 4 ARG A 145 112.61 -39.81 REMARK 500 4 ALA A 156 -46.17 -139.62 REMARK 500 5 VAL A 144 116.46 175.09 REMARK 500 5 ARG A 145 107.71 -166.49 REMARK 500 5 ALA A 156 -46.23 -139.68 REMARK 500 6 SER A 142 59.64 -113.16 REMARK 500 6 VAL A 144 116.47 175.10 REMARK 500 6 PHE A 148 172.44 -46.61 REMARK 500 6 ALA A 156 -46.21 -139.61 REMARK 500 7 VAL A 144 116.49 175.07 REMARK 500 7 PHE A 148 158.69 -41.69 REMARK 500 7 LEU A 151 165.08 -45.06 REMARK 500 7 ALA A 156 -46.20 -139.60 REMARK 500 8 VAL A 144 116.46 175.07 REMARK 500 8 ARG A 154 88.96 -151.83 REMARK 500 8 ALA A 156 -46.26 -139.81 REMARK 500 9 SER A 142 55.22 -151.85 REMARK 500 9 VAL A 144 116.46 175.07 REMARK 500 9 ARG A 145 96.95 -167.82 REMARK 500 9 ALA A 156 -45.90 -140.47 REMARK 500 10 SER A 142 58.93 -167.47 REMARK 500 10 VAL A 144 116.48 175.06 REMARK 500 10 ARG A 145 106.06 -56.49 REMARK 500 10 ALA A 156 -45.86 -140.48 REMARK 500 REMARK 500 REMARK: NULL

DBREF 1BCV A 141 159 UNP P03308 POLG_FMDVA 864 882

SEQRES 1 A 20 ACE GLY SER GLY VAL ARG GLY ASP PHE GLY SER LEU ALA SEQRES 2 A 20 PRO ARG VAL ALA ARG GLN LEU

HET ACE A 140 6

HETNAM ACE ACETYL GROUP

FORMUL 1 ACE C2 H4 O

LINK C ACE A 140 N GLY A 141 1555 1555 1.33

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000